$150.0 Million
Point Biopharma Inc.
At-the-Market Offering
Joint Placement Agent
$175.5 Million
Tempest Therapeutics Inc.
Reverse Merger
Financial Advisor
$257.0 Million
Kymera Therapeutics LLC
Follow-On Offering
Passive Bookrunner
Ology Bioservices, Inc.
Ology Bioservices, Inc. has been acquired by National Resilience, Inc.
Financial Advisor
Galderma Holding S.A.
Galderma S.A., a portfolio company EQT, has divested Alchemee (formerly the Proactiv Company) to Taro Pharmaceuticals Industries Ltd.
Financial Advisor
$85.0 Million
SilverSpikeInvestment
Silver Spike Investment Corp
Initial Public Offering
Active Bookrunner
BioInsights Report - Gene Therapy 4.0: Crouching Before it Leaps – Despite Setbacks, Gene Therapy Field Continues to Advance
October 06 / READ
$141.0 Million
Omega Therapeutics, Inc.
Initial Public Offering
Active Bookrunner
$176.6 Million
Ventyx Biosciences
PIPE
Joint Placement Agent
$45.1 Million
Mesoblast Limited
PIPE
Sole Placement Agent
Subscribe to Biopharma

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.